Investment opportunity

We are looking for funding in order to move forward with our research and development. Read more below.

Investment opportunity

404 - Page was not found

Sivua eng/investors/for-current-shareholders ei löytynyt tältä sivustolta

Search results

Investors(Page)
Information for investors Tietoa sijoittajille The company calls for additional investors Medicortex Finland Plc is giving current shareholder...

Medicortex Finland Is Developing Diagnostic Tool Based on Biomarkers for Traumatic Brain Injury and Stroke(News)
n injury. Another mission for the company is to develop a pharmaceutical therapy which will limit the long-term effects of brain injury, inclu...

The TBI Market(Page)
al Problem and Unmet Need for Immediate Diagnosis Each year, there are approximately 69 million new cases of traumatic brain injury (TBI) glob...

Technology(Page)
biomarker diagnostic test for TBI may be of use in identifying individuals with TBI, who are at risk of secondary brain injury and therefore r...

Letter from CEO(Page)
the head. Typical reasons for TBI are falls, traffic accidents, contact sport injuries and combat injuries. TBI remains a “silent epidemic” du...

Letter from CEO(Page)
the head. Typical reasons for TBI are falls, traffic accidents, contact sport injuries and combat injuries. TBI remains a “silent epidemic” du...

Medicortex Finland Oy: Clinical Trial Extended for Detection of Mild Traumatic Brain Injury(News)
three Finnish hospitals. For more information please look at the link. ...

Share price now 6.40 euro / Osakkeen hinta nyt 6,40 euroa(News)
iptions. Please see the information on our Investors pages.Alkaen 12.1...

Still a little time left to raise Business Finland decision's initial capital!(News)
s to invest! Instructions for subscribing are...

Traumatic brain injury (Page)
or prone to interference for diagnosing mild TBI. Inadequate approaches to diagnosing mild TBI creates a need for significant improvement in ...

Board of Directors(Page)
, in his last position, before Medicortex, he was the CEO of BrainStorm Cell Therapeutics (BCLI), a publicly-traded company in New York. No. o...

Board of Directors(Page)
, in his last position, before Medicortex, he was the CEO of BrainStorm Cell Therapeutics (BCLI), a publicly-traded company in New York. No. o...

Why invest?(Page)
, a new diagnostic method for a huge need – detection of brain injury and concussion. Investments will be used for the clinical trial and prod...

Medicortex was granted a European patent for biomarker diagnostics(News)
gnostics patent “A Method for Determining a Lectin-binding Glycan Indicative to Traumatic Brain Injury” was granted by the European Paten...

Art auction(Page)
as started to raise funds for the development of a diagnostic kit for people suffering from Traumatic Brian Injury. We explained to the member...

Company Profile(Page)
sh ELY-center (The Centre for Economic Development, Transport and the Environment), as well as from private investors. Our nearest aim is to d...

Business Strategy(Page)
ay, no accurate diagnosis for TBI exists, and diagnosis is based on neurological evaluation and imaging methods that are not always sufficient...

Why Invest?(Page)
lacking a reliable method for detecting mild TBIs, Medicortex Finland Oyj and Fepod Oy Ltd decided to team up to offer a competitive edge wi...

Medicortex was granted a European patent for COVID-19 diagnostics // Medicortexille myönnetty COVID-19 diagnostiikka patentti Euroopassa(News)
iagnostics patent “Method for Determining Coronavirus and Kit for the Same” was granted in the European Union (EP patent No. 3911956). The pat...

Articles of Association(Page)
ater than nine (9) days before the record date of the General Meeting. The notice shall be delivered to the shareholders by means of a notice ...

Scientific and Clinical Advisory Board(Page)
l positions in Neurology, for example, the Chairman of the Division of Clinical Neurosciences at Turku University Hospital. He has served as a...

Invest Now(Page)
! Subscription agreements for the campaign (14-28 November) In English: 2023 November Subscription Agreement In Finnish: 2023 Marraskuu Merkin...

Medicortex is looking for new investors (News)
A share issue is open for new investors. You can support the development of a handheld concussion quick-test by becoming and investor and...

Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland(News)
is to analyze the samples for the presence of the unique biomarkers for traumatic brain injuries. ...

Company Profile(Page)
sh ELY-center (The Centre for Economic Development, Transport and the Environment), as well as from private investors. Our nearest aim is to d...

Drug development program(Page)
ith lipophilic properties for crossing the blood-brain-barrier (BBB), and each with at least two of the following neuro-protective functions: ...

Medicortex has a fundraising campaign 10-24.5.2023(News)
art of the success!For additional information, please visit our...

IP rights(Page)
alia 3. Device and Method for Detecting of Brain injury in a Subject PCT application WO 2021/099677 Australian innovation patent No. 202010447...

Immateriaalioikeudet(Page)
liassa ”Device and Method for Detecting of Brain Injury in a Subject”  PCT-hakemus WO 2021/099677 Australian innovaatiopatentti No. 2020104474...

Dr. Kvist attending Clinical Trials Excellence Forum 2016(News)
linical Trials Excellence Forum 2016 (12. - 14. October, Munich)...

Dr. Harel will attend the European Life Sciences CEO Forum(News)
;10th Annual European Life Sciences CEO Forum...

Approval of a patent for a drug candidate / Lääkemolekyylipatentti hyväksytty(News)
in Finland and in the USA for its drug molecule candidates. Please see our...

Medicortex Finland Oy announces reaching the halfway point in the clinical trial for children and adolescents.(News)
al trial for detection of mild traumatic brain injury (TBI) and concussion in children and adolescent, which...

Medicortex's Annual General Meeting on May 29th(News)
of May 2017 at 15:00. All current shareholders are invited to take part and attend the meeting in our office...

Crowdfunding successfully completed / Joukkorahoituskampnaja päättynyt(News)
aign using Invesdor's platform. We have more than 80 new shareholders supporting our ongoing activities.Medicortex on saavuttanut tavoi...

Medicortex has published a press release regarding the outcome of the fundraising campaign(News)
/tiedote/new-shareholders-for-medicortex?publisherId=49600577&releaseId=69967910" class="aloha-link-text" target="_blank">here...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous(News)
future development plans for Medicortex. Medicortexin tieteellis-kliininen toimikunta kokoontui 28. maa...

Press release: A clinical trial is a significant accomplishment for Medicortex(News)
ignificant-accomplishment-for-medicortex?publisherId=49600577&releaseId=50277257" class="">press release about the clinical trial...

The 24th Annual Israel Society for Neuroscience Meeting(News)
-Functional Drug Approach for the Treatment of Brain Injury. See more at http://www...

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland(News)
ts a remarkable milestone for Medicortex. Please see the ...

A New Clinical Trial for a Novel Brain Injury Biomarker(News)
news/a-new-clinical-trial-for-a-novel-brain-injury-biomarker.html" class="aloha-link-text" target="_blank">Press release in English--...

Medicortex Announces Progression in the Clinical Trial for Detection of Mild Traumatic Brain Injury in Children(News)
ression-of-clinical-trial-for-detection-of-mild-traumatic-brain-injury-in-children?publisherId=49600577&releaseId=69883097" class="aloha-l...

A utility patent was approved for Medicortex in China(News)
cting the novel biomarker for concussion diagnostics was approved in the USA as well as Europe...

Business Finland Granted Funding for Medicortex(News)
s-Finland-Awarded-Funding-for-Medicortex" class="aloha-link-text" target="_blank">Read the press release from Businesswire. ...

Medal award ceremony for Dr. Mårten Kvist(News)
ly awarded The Gold Medal for Life’s Work and a diploma as appreciation to his achievements...

Proof of concept(Page)
studies Medicortex has performed preclinical research comparing fluid biopsies from normal and injured lab animals. The results showed some un...

Product to be Developed(Page)
s an electrochemical test for quantitative detection of Traumatic Brain Injury biomarkers. The test will be developed in collaboration with Fe...

Medicortex Finland Receives an Innovation Grant(News)
unar Bäckström foundation for the development of a diagnostic kit for traumatic brain injuries. The company is happy to receive this recogniti...

Art Helping TBI Research(News)
as started to raise funds for the development of a diagnostic kit for people suffering from Traumatic Brain Injury through the auctioned sale...

Last Reminder to Holders of Incentive Options(News)
ncentive options issued before June 2022, to exercise the options (convert to shares) no later than 16 December 2023, or, to switch to...

Biomarker R&D program(Page)
l Arrow Medicortex has performed preclinical research. The results showed some unique biomarkers released as biodegradation products after a h...

Second clinical trial(Page)
the samples were analysed for the precence of the biomarker.  Sample analysis showed statistically significant increase in biomarker level.  2...

Management(Page)
c Officer since: 2021 ( before that: 'Head of R&D' since 2015) About: Dr. Välimaa , the head of R&D since 2015, has a PhD degree in Molecular ...

General Meetings(Page)
enclosed file below. NB!  For a shareholder who is planning to participate in the meeting; please note the due dates and  compulsory advance e...

Medicortex received an innovation award(News)
tion grant of 15 000€ for the development of the diagnostic kit...

Dr. Harel presenting at ESTES Congress 2017(News)
stract has been nominated for the Best Poster Award in the...

The second brain injury awareness meeting 12.2.2018(News)
out Medicortex’s solution for the diagnostics problem. After the presentations, we had active and fruitful discussion. Thank you for all parti...

Annual General Meeting on 30th May / Varsinainen yhtiökokous 30.5.(News)
dicortex's Annual General Shareholders' meeting will be held on 30th May 2018 at 3.00 p.m. in the premises of the company in Turku, Finland. A...

Medicortex presentation in Monaco (News)
Additional information regarding the presentation by Dr. Adrian Harel from Medicortex Finland Oy in Monaco (September 28, 2018 - Novo...

Annual General Meeting on 29th May / Varsinainen yhtiökokous 29.5.(News)
edicortex' Annual General Shareholders' meeting will be held on 29th May 2019 at 3.00 p.m. in the premises of the company in Turku, Finland. A...

Medicortex Finland Plc has published a press release regarding announcement of IPO(News)
offering (IPO) and apply for listing on Nasdaq First North Growth Market Finland. The IPO is to take place 13.-22.6.2022. Rea...

Management(Page)
atures influencing the performance of biochemical binding assays. Picture5 Chief Operating Officer (COO) Chief Operating Officer since:  About...

Management(Page)
atures influencing the performance of biochemical binding assays. Pihla Miettinen Chief Operating Officer (COO) Chief Operating Officer since:...

Dr. Harel is the Face of the Month in Turku Science Park's Newsletter(News)
land which develops drugs for reducing the impacts of traumatic brain injury and diagnostics for determining the extent of injury. The goal is...

Medicortex Finland Held Discussions with TEKES(News)
/">Finnish Funding Agency for Innovation, TEKES. The company presented their updated information and future plans...

The First Clinical Trial is Approaching(News)
ers. The study will be performed in collaboration with the Turku University Hospital (Tyks), and the project will be funded by The Finnish Fun...

Military accidents can be diagnosed using Medicortex's kit - A new press release(News)
to find the actual reason for their problems...

Extraordinary General Meeting / Ylimääräinen yhtiökokous(News)
Extraordinary shareholders' meeting will be held on Monday 30th October 2017 at 3:00 p.m. in the premises of the company in Turku, Finland...

Medicortex participated in a press conference #pääasia(News)
t 7.11. in Biocity Turku. Former ice hockey player Tommi Kovanen and former basketball player Tiina Sten, as well as active ice hockey player...

We are opening new funding round with old terms(News)
share issue with options for a two weeks 15.1.-29.1. - use your opportunity now! Read more form...

Medicortex presentation in Monaco (News)
estors meeting in Monaco. For more information please look at the link. ...

Medicortex Announces Receiving a 1.1 Million Dollars Research Grant from the US Department of Defense / Medicortex Finland Oy:lle tutkimusrahoitusta Yhdysvaltain Puolustusministeriöltä(News)
_blank">press release for detailed information. Medicortex:lle myönnettiin 1,1 milj.$ apuraha Yhdysvaltain Puolustusm...

Extraordinary general meeting / Ylimääräinen yhtiökokous (News)
th annexes is sent to the shareholders. Shareholders intending to attend must notify to medicortex@medicortex.fi no later than 11th January 20...

Extraordinary General Meeting / Ylimääräinen yhtiökokous(News)
th annexes is sent to the shareholders. Shareholders intending to attend must notify to medicortex@medicortex.fi no later than 29th March 2022...

Medicortex Signed a 2 Million Dollars Research Grant Contract with the US Department of Defense(News)
f about 2 million dollars for its project plan to develop a rapid test for detection of mild traumatic brain injury (TBI) and concussion.&nbsp...

Jonne Virtanen lähti bioteknologiayhtiön mainoskasvoksi – ”Hiljaista epidemiaa esiintyy urheilujoukkueissa”(News)
tbCJ9-->...

In the press: Turun Sanomat has published an article about Medicortex(News)
ement in gaining approval for its project plan from the US Department of Defense (DoD). To read the full article, follow this link:...

Aivovamman tunnistaminen sylkitestillä etenee – turkulainen yritys listautuu pörssiin(News)
tbCJ9-->...

Medicortex is having a campaign 5 – 20 January 2023(News)
e success!For additional information, please visit our...

Medicortex had a Workplace Well-being day!(News)
cluded several activities for team bonding and some for educational purposes...

Clinical trials(Page)
cal trials Phase I We are currently running a proof-of-concept clinical trial in collaboration with Turku University Hospital (Tyks). Samples ...

Assay development plan(Page)
Plan A two-year R&D plan for development of the diagnostic kit Assay development plan...

Press releases(Page)
granted a European patent for detection of biomarker indicative to brain injury" - published 24.1.2024. "Business Finland supporting Medicorte...

Osallistu webinaariin 7.8.2020(Page)
0]; s.parentNode.insertBefore(t,s)}(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '752350115590...

Tietoa meistä(Page)
0]; s.parentNode.insertBefore(t,s)}(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '752350115590...

Reports and presentations (Page)
ties system). Financial information The latest approved Financial statement and auditor's report: Medicortex Tilinpaatos 2022 Medicortex Finan...

Hallitus(Page)
on of the Health Sector Reform Programme in Egypt”, sekä vastaavanlaisessa projektissa Lesothossa. WHO:n neuvonantajana hän on johtanut projek...

Lehdistötiedotteet(Page)
granted a European patent for detection of biomarker indicative to brain injury"  - julkaistu 24.1.2024. "Business Finland tukee Medicortexia"...

Hallitus(Page)
on of the Health Sector Reform Programme in Egypt”, sekä vastaavanlaisessa projektissa Lesothossa. WHO:n neuvonantajana hän on johtanut projek...

Financial and Developmental Timeline(Page)
1.1 million Euros. In the current fundraising, the goal is to raise up to 100 000 € to cover the cost of the first developmental phase (feasib...

Medicortex's Annual General Meeting on May 30th(News)
r on the 30th of May. All shareholders are invited to take part in the meeting...

"The silent epidemic" on radio podcast 22nd April at 10 pm EST(News)
at 10pm. EST. Tune in for Dr. Harel's interview at Brain Injury Radi...

Medicortex Featured in Local Newspaper, Turun Sanomat(News)
im coming to Finland, the current status of the diagnostic methods of TBI and the future aspirations of the company. You can read the article...

Medicortex has completed collection of clinical samples(News)
itets-centralsjukhus-aucs-for-en-kemisk-snabbtest-av-akuta-hjarnskadefall?publisherId=1097392&releaseId=1097403" class="aloha-link-text" t...

Medicortex has launched a crowdfunding campaign(News)
op a rapid diagnostic kit for brain injury detection by joining the campaign!...

Medicortex Finland using crowdfunding to help develop brain injury diagnostics(News)
e most beneficial purpose for our testing kit is increasing the detection of TBIs and minimizing misdiagnoses," accor...

Development of the brain injury test sped up by crowdfunding(News)
ieringskampanj-en-losning-for-battre-diagnostik-av-hjarnskador/" class="aloha-link-text" target="_blank">Swedish...

An interview published(News)
w-biomarker-has-potential-for-sideline-diagnosis-of-traumatic-brain-injury/36254/" class="aloha-link-text" target="_blank">MedicalResearch.com...

Third study site has been added to the clinical trial (News)
The latest information regarding the clinical trial has been updated to the...

Scientific and Clinical Advisory Board had a meeting(News)
r and submit the protocol for approval to the ethical committee. ...

Medicortex was shortlisted as a finalist to the Europabio´s Most Innovative European Biotech SME Awards(News)
d by European Association for Bioindustries. Being chosen as a runner-up enabled us to attend and present our company in the Europabio event o...

Clinical Trial Completed / Kliininen tutkimus päättynyt(News)
emical studies will be performed on the samples...

Medicortex featuring in Turun Sanomat newspaper / Medicortex Turun Sanomissa(News)
In the theme of the current brain week, the major newspaper in Turku published an article on Medicortex. ...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous (News)
ionally, a new indication for the biomarker was discussed. Medicortexin tieteellis-kliininen toimikunta kokoontui 10. kesäkuut...

Medicortex was chosen as the winner of TechBBQ’s pitching competition! (News)
is tremendously grateful for being chosen as the Winner and receiving 25,000 DKK! Thank you everyone at TechBBQ and all that participated. We...

Medicortex featured in an Israeli newspaper, News1 (News)
>A revolutionary solution for the immediate detection of concussions” featured in a Hebrew newspaper.  ...

Medicortex wins the Life Science Pitching competition at Y Science 2019 (News)
the jury and the audience for a wonderful event!...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous(News)
trial as well as the plan for the pediatric 3rd clinical trial.  Medicortexin tieteellis-kliininen toimik...

Patent Issued in Israel / Patentti Israelissa(News)
pany's chemical compounds for the drug development program. Please see our...

Medicortex CEO, Dr Adrian Harel participated in a pitching to Finnish business angels(News)
vited to pitch Medicortex for FiBAN, the Finnish business angels’ network. Adrian presented the company in a webinar due to the COVI...

Annual General Meeting on 29th May 2020 / Varsinainen yhtiökokous 29.5.2020(News)
exes has been sent to the Shareholders.Varsinainen yhtiökokous pidetään 29.5.2020 klo 15:00 Turussa. Kokouskutsu liitteineen o...

Medicortex received a 50 k€ grant / Medicortex Finland Oy:lle myönnettiin 50k€ suuruinen kehittämisavustus (News)
t from the Finnish Centre for Economic Development, Transport and the Environment to support the development of the concussion quick-test&nbsp...

Medicortex on saanut kerättyä kaikki potilaat kolmanteen kliiniseen tutkimukseen (News)
-an-Important-Achievement-for-Medicortex-Finland" class="" target="_blank">Linkin takaa voit lukea lehdistötiedotteen (englanniksi)...

Patent issued in Canada / Patentti myönnetty Kanadassa(News)
fice has granted a patent for our core technology in biomarker diagnostics. Please see the...

Annual General Meeting on 28th May 2021 / Varsinainen yhtiökokous 28.5.2021(News)
exes has been sent to the Shareholders.   Medicortex Finland Oy:n Varsinainen yhtiökokous pidetään 28.5.2021 klo 15:...

Medicortex and Dividend Announce a Pre-IPO Investment / Medicortex ja Dividend Julkistavat Ennakko-IPO Sijoituksen(News)
e-IPO round Medicortex is currently conducting...

Medicortex Closes Successful Pre-IPO Funding Round(News)
ic CA. The IPO is planned for 2022...

Good News from Finland writes an article about Medicortex(News)
nk">here (Scroll down for the section about Medicortex)...

Medicortex has published a company release announcing that the US Department of Defense has approved Company’s project plan(News)
mpany starts negotiations for a research grant of up to 2 million dollars.Read more:...

Medicortex Announces a Fundraising Campaign (extended to 19 July)(News)
es up. Funds will be used for development of the TBI test kit.Read more:...

Happy Holidays(News)
Thank you for your cooperation in 2022...

Medicortex subscription campaign ends 20.1.2023 // Medicortex osakeanti päättyy 20.1.2023!(News)
ie!More information and subscription agreement are...

Medicortex's new press release: the outcome of the two fundraising rounds(News)
ing-2023-company-grateful-for-the-public-interest?publisherId=49600577&releaseId=69983245" class="aloha-link-text" target="_blank">here...

Uusi lehdistötiedote: Turun kaupunki myönsi Medicortexille TKI-setelin(News)
nt, and innovation -grant for a project in cooperation with Turku University. Find the press release...

Muistutus kannustinoptioiden haltijoille(News)
>30.11.2023. Olemme informoineet optionhaltijoita kesäkuussa 2022 ja uudelleen kesäkuussa 2023. Tarkemmat tiedot asiasta löytyvät optionha...

Medicortex's new brain injury test: share issue 14 - 28 November 2023(News)
0 € (1 € / share). More information here...

Medicortexin osakeanti päättyy huomenna / Medicortex's share issue ends tomorrow(News)
brain injury test! More information here...

Medicortex receives extension to Business Finland funding decision(News)
es receiving an extension for raising the starting equity required by the funding decision from Business Finland. The funds will be used to ex...

Dr. Harel attended the 7th International Conference on Biochemical Markers for Brain Damage(News)
Dr. Adrian Harel attended the BMDB 201...

A clinical trial for children started / Kliininen tutkimus lapsipotilaille alkanut(News)
Medicortex has started its third clinical trial at Satasairaala hospital in Pori, Finland. This trial will focus on children and adolescen...

Medicortex Finland Oy Announces Issuance of a Patent for Brain Injury Biomarker(News)
European Patent Office (EPO) has issued a patent covering a new diagnostic kit technology...

Medicortex was granted a Finnish patent for tissue damage diagnostics // Medicortexille myönnetty patentti Suomessa kudosvaurion havaitsemiseksi(News)
Medicortex's tissue damage diagnostics patent “Method of detecting tissue damage” was granted in Finland (FI patent No. 130428)...

Medicortex in a Swedish Newspaper (News)
Medicortex was featured in Swedish newspaper Åbo Underrättelser in the article: "Åboföretag utvecklade "slickepinne" som ska diag...